Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The study underscores the potential of perioperative durvalumab in combination with neoadjuvant chemotherapy to significantly improve event-free survival and pathological complete response in patients with resectable NSCLC.
Oncology, Medical November 6th 2023
MDLinx
The discovery that chemotherapy-induced cognitive impairment, or “chemobrain,” may be linked to an excess of calcium inside cells opens new avenues for potential therapies. This breakthrough could lead to treatments that restore cognition in patients experiencing these symptoms.
Neurology November 1st 2023
Oncology News Central (ONC)
This recent study suggests that systemic treatment with chemotherapy plus immunotherapy may allow patients with muscle-invasive bladder cancer (MIBC) to avoid radical cystectomy.
Oncology, Medical October 23rd 2023
ACP Internist
Test your knowledge and clinical acumen with this quiz, featuring a case study on chemotherapy regimens for metastatic adenocarcinoma of the colon.
Gastroenterology October 19th 2023
Cancer Therapy Advisor
Explore how high-dose hyperfractionated thoracic radiotherapy is setting new standards in LS-SCLC treatment.
Oncology, Medical October 17th 2023
This study provides compelling evidence on the role of adjuvant chemotherapy in hormone-receptor–positive, HER2-negative breast cancer with positive lymph nodes, revealing a significant impact based on menopausal status.
Oncology, Medical October 2nd 2023